Avapro and Cozaar are now the first drugs APPROVED for treating kidney disease in patients with type 2 diabetes and hypertension
October 2002
Avapro and Cozaar are now the first drugs APPROVED for treating kidney disease in patients with type 2 diabetes and hypertension.
For years clinicians used ACE inhibitors for these patients. But no ACE inhibitor is actually APPROVED for this use.
Avapro (irbesartan) and Cozaar (losartan) slow progression of kidney disease...similar to ACE inhibitors. Other angiotensin receptor blockers probably work too.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote